## 

## 

## 

||||
|---|---|---|
|Index||Page|
|Report ofthe trustees|||
|Report ofthe auditors||7-9|
|Statement offinancial activities||10|
|Balance sheet|||
|Cash flow statement||12|
|Notes forming part ofthe financial|statements|13-21|





## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

|Directors/Trustees|Directors/Trustees||Maria Dolores Manterola|Maria Dolores Manterola|(aka|Lola Manterola) - Chairman|Lola Manterola) - Chairman|Lola Manterola) - Chairman|
|---|---|---|---|---|---|---|---|---|
||||Nicola Louise Amoroso||||||
||||Marta Brime (Secretary ofthe|||Board of|Trustees)||
||||Fernando Delgado||||||
||||Eleonora Geraldine|Creaturo|||||
||||Nuria Marti||||||
||||Diego Megia||||||
||||Alvaro Portanet||||||
||||Snigdha Singh||||||
||||Josefa Diaz Mercado||||||
||||Chris Ciauri (appointed 27 January 2022)||||||
|Treasurer|||Ana De Paz||||||
|Company|number||7493363||||||
|Registered|charity|number|1140193||||||
|Registered|office||Quadrant<br>House - Floor||6, 4|Thomas|More Square,|London|
||||E1W 1YW||||||
|Auditors|||UHY Hacker Young,|Quadrant||House, 4 Thomas More||Square,|
||||London E1W 1YW||||||
|Bankers|||Clydesdale<br>Bank, 88|Wood Street,|||||
||||London EC2V 7QQ||||||
|Solicitors|||Bates Wells k Braithwaite||London LLP||||
||||2-6 Cannon Street, London||EC4M 6YH||||





## 

## 



## 

## 

## 

## 

## 

## 



## 

## 



## 

## 



## 

## 

||||Unrestricted|Restricted|Total|Unrestricted|Restricted|Total|
|---|---|---|---|---|---|---|---|---|
||||funds|funds|funds|funds|funds|funds|
||||||2021|||2020|
|||Notes|||||||
|Incoming<br>resources|||||||||
|Income from:|||||||||
|- Donations<br>and legacies||3.1|149,287|15,000|164,287|233,124|15,000|248,124|
|-Other trading activities||3.2|1,683,198||1,683,198|790,473|-|790,473|
|-Investments||3.3|1,448||1,448|2,156||2,156|
|Total incoming<br>resources|||1,833,933|15,000|1,848,933|1,025,753|15,000|1,040,753|
|Expenditure<br>on:|||||||||
|Raising funds:|||||||||
|Fundraising<br>events|||173,182||173,182|93,011||93,011|
|Charitable<br>activities:|||||||||
|Donations<br>made|||757,845|15,000|772,845|475,976|15,000|490,976|
|Total|||931,027|15,000|946,027|568,987|15,000|583,987|
|Net movement<br>in funds|||902,906||902,906|456,766||456,766|
|Reconciliation<br>offunds|||||||||
|Total funds brought|forward||1,297,310|-|1,297„310|840,544||840,544|
|Total funds carried|forward||2,200,216|—|2,200,216|1,297,310|-|1,297,310|





## 

## 

||||||31December||31December|
|---|---|---|---|---|---|---|---|
||||||2021||2020|
||||Notes|||||
|Fixed assets||||||||
|Tangible assets|||||13,752||18,911|
|Current assets||||||||
|Debtors||||300,742||116,278||
|Cash at bank||||1,953,648||1,171,830||
|||||2,254,390||1,288,108||
|Creditors: Amounts||falling due||||||
|within one|year|||(67,926)||(9,709)||
|Net current|assets||||2,186,464||1,278,399|
|Total assets|less current liabilities||||2,200,216||1,297,310|
|Net assets|||||2,200,216||1,297,310|
|Funds ofthe|charity:|||||||
|Unrestricted|funds||||2,200,216||1,297,310|
|Restricted funds||||||||
||||||2,200,216||1,297,310|






## 

## 

||||||31Dec 2021|31Dec 2020|
|---|---|---|---|---|---|---|
|||||Notes|||
|Operating<br>dk investing||activities|||||
|Receipts ofinterest|||||1,448|2,156|
|Receipts ofother cash|||||1,660,723|1,030,359|
|Payment ofcharitable|grants||||(688,321)|(450,898)|
|Payment ofexpenses|||||(197,190)|(135,312)|
|Depreciation<br>charge of||tangible<br>assets|||5,158|5,158|
|Increase in cash from|||||||
|operating &investing|activities||||781,818|451,463|
|Increase in cash|||||781,818|451,463|
|(A) Reconciliation<br>of|changes in resources to net cash||||||
|inflow from operating &investing|||activities||||
||||||2021|2021|
|Depreciation oftangible||fixed assets|||5,158|5,158|
|Net incoming resources|||||902,906|456,765|
|(Increase)/ Decrease in||debtors|||(184,462)|1,406|
|Increase/ (Decrease) in|creditors||||58,216|(11,866)|
||||||781,818|451,463|
|(B) Analysis ofchanges||in cash balances during||the year|||
||||||2021|2021|
|Cash at beginning ofperiod|||||1,171,830|720,367|
|Cash at end ofperiod|||||1,953,648|1,171,830|
|Increase in cash|||||781,818|451,463|





## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

|Analysis ofstaff costs|||
|---|---|---|
||2021|2020|
|Salaries and Wages|57,516|50,885|
|Social Security Costs|790|1,175|
|Pensions|1,312|1,129|
||59,618|53,189|



## 




## 

|4|Analysis ofcharitable|Analysis ofcharitable|expenditure|Unrestricted|Unrestricted|funds||Restricted funds|Restricted funds|||
|---|---|---|---|---|---|---|---|---|---|---|---|
|||||Raising|Charitable|||Raising|Charitable||31Dec|
|||||Funds||activities|Sub-total|funds|activities|Sub-total|2021 Total|
||Year ended 31Dec 2021:|||||||||||
||Activities undertaken|directly||||||||||
||Fundraising<br>events|||142,463|||142,463||||142,463|
||Donations<br>made:|||||||||||
||-CRIS Cancer France|||||30,050|30,050||||30,050|
||-CRISCancer Spain|||||56,784|56,784||||56,784|
||- Institute ofCancer Research|||||586,487|586,487||15,000|15,000|601,487|
|||||142,463||673,321|815,784||15„000|15,000|830,784|
||Support costs|||||||||||
||Accountancy|||1,058||2,242|3,300||||3,300|
||Audit Fees|||2,116||4,484|6,600||||6,600|
||Employee costs|||13,189||47,374|60,563||||60,563|
||General office costs|||10,019||21,233|31,252||||31,252|
||Professional<br>costs|||2,684||5,687|8,371||||8,371|
||Depreciation|||1,653||3,504|5,157||||5,157|
|||||30,719||84,524|115,243||||115,243|
|||||173„182||757,845|931,027||15,000|15,000|946,027|





## 

|F|OR THE YEAR ENDE|OR THE YEAR ENDE|D 31DECE|MBER 2021|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|4|Analysis ofcharitable||expenditure|(continued)|||||||||
||||||Unrestricted||funds||Restricted funds||||
||||||Raising|Charitable|||Raising|Charitable||31Dec|
||||||Funds||activities|Sub-total|funds|activities|Sub-total|2020 Total|
||Year ended|31 Dec 2020:|||||||||||
||Activities undertaken||directly||||||||||
||Fundraising|events|||32,297|||32297||||32,297|
||Donations made:||||||||||||
||-CRIS Cancer France||||||28,550|28,550||||28,550|
||-CRIS Cancer Spain<br>- Institute ofCancer Research||||||3,350<br>403,998|3,350<br>403,998||15,000|15,000|3,350<br>418,998|
||||||32,297||435,898|468, 195||15,000|15,000|483,195|
||Suppottcosts||||||||||||
||Accountancy||||962||7,038|3,000||||3,000|
||Audit Fees||||1,924||4,076|6,000||||6,000|
||Employee costs||||46,420||9,790|56,210||||56,210|
||General office costs||||8,545||18,107|26,652||||26,652|
||Professional|costs|||1,210||2,563|3,773||||3,773|
||Depreciation||||1,653||3,504|5,157||||5,157|
||||||60,714||40,078|100,792||||100,792|
||||||93,011||475,976|568,987||15,000|15,000|583,987|





## 

## 

|5|Tangible fixed ass|ets|||||
|---|---|---|---|---|---|---|
||||||Fixtures||
|||||||Total|
||||||Fittings||
||Cost or valuation:||||||
||At 1 January 2021||||25,788|25,788|
||Additions||||||
||At 31December 2021||||25,788|25,788|
||Depreciation:||||||
||At 1 January 2021||||6,878|6,878|
||Charge for the year||||5,158|5,158|
||At 31December 2021||||12,036|12,036|
||Net book value:||||||
||At 31December 2021||||13,752|13,752|
||At 31December 2021||||18,910|18,910|
|6|Debtors: amounts|falling|due with one year:||||
||||||31Dec 2021|31Dec 2020|
|||||||f.|
||Trade Debtors||||290,842|104,078|
||Prepayments||||5,400|7,700|
||Other debtors||||4,500|4,500|
||||||300,742|116,278|
|7|Other creditors: amounts||falling due within one year||||
||||||31Dec 2021|31Dec 2020|
|||||||f.|
||Other creditors and|accruals|||67,926|9,709|
|8|Deferred Income||||31Dec 2021|31Dec 2020|
||Deferred income is|included||within:|||
||Creditors due within one year||||||
||Deferred income at|1 January||2021||12,373|
||Released from previous years|||||(12,373)|
||Resources deferred|in the year|||||





## 

## 

|9|Financial|instruments|31Dec 2021|31Dec 2020|
|---|---|---|---|---|
||Carrying|amount offinancial assets:|||
||Debtors||290,842|104,078|
||Prepayments||5,400|7,700|
||Other debtors||4,500|4,500|
||||300,742|116,278|
||Carrying|amount offinancial liabilities:|||
||Other creditors||(67,926)|(9,709)|
||||232,816|106,569|



|||31Dec 2021|31Dec 2020|
|---|---|---|---|
|Within|1 year|21,600|18,900|
|2 —5 years||32,400|54,000|
|||54,000|72,900|



|nalysis ofc|haritable<br>funds|||||
|---|---|---|---|---|---|
|||Balance at|Incoming|Resources|Balance at|
|||1Jan 2021|resources|expended|31Dec 2021|
||||f.|||
|Unrestricted|funds:|||||
|General Funds||1,297,310|1,833,933|(931,027)|2,200,216|
|||1,297,310|1,833,933|(931,027)|2,200,216|
|Restricted funds|||15,000|(15,000)||
|Total||1,297,310|1,848,933|(946,027)|2,200,216|





## 

## 

||Unrestricted|Restricted|Total|Total|
|---|---|---|---|---|
||funds|funds|31Dec2021|31Dec2020|
|Fixed assets|13,752||13,752|18,911|
|Debtors|300,742||300,742|116,278|
|Bank|1,953,648||1,953,648|1,171,830|
|Creditors|(67,926)||(67,926)|(9,709)|
||2,200,216||2,200,216|1,297,310|



## 

## 

## 

## 

